Literature DB >> 10861799

Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis.

S W Hulet1, S O Heyliger, S Powers, J R Connor.   

Abstract

We previously demonstrated ferritin binding is specific to white matter in mouse and human brain tissue and is not found within Multiple Sclerotic plaques. These results suggest that ferritin receptors are selectively expressed on oligodendrocytes. The present studies were designed to test the hypothesis that oligodendrocyte progenitor cells selectively bind ferritin and internalize it by methods consistent with receptor-mediated endocytosis. Using a cell culture system enriched for oligodendrocyte progenitor cells, we determined, that oligodendrocyte progenitor cells bind ferritin in a saturable and competitive manner with a K(d) of 5 nM and a receptor density of 0.06 fmol bound/20,000 cells. FITC tagged ferritin is internalized by A2B5, O4 or CNPase expressing cells in the culture, but not by GFAP+ cells. The uptake of ferritin into the oligodendrocyte progenitors was inhibited by treating the cells with inhibitors of receptor mediated endocytosis (hypertonic medium, potassium deficient medium, ATP depletion, sulfhydryl reagents). In addition exogenous ferritin decreased iron responsive element/iron regulatory protein binding indicating that the iron within the internalized ferritin is released and contributes to the intracellular iron pool. Given the relatively high amount of iron that can be delivered via ferritin, and the selective distribution of ferritin receptors in the white matter tracts in vivo, we propose that ferritin is a major source of iron for oligodendrocytes. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861799     DOI: 10.1002/1097-4547(20000701)61:1<52::AID-JNR6>3.0.CO;2-T

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

2.  Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation.

Authors:  David L Schonberg; Dana M McTigue
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

3.  Cerebrospinal fluid ferritin in chronic hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Hidenori Suzuki; Masatoshi Muramatsu; Katsuhiro Tanaka; Hiroaki Fujiwara; Tadashi Kojima; Waro Taki
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

4.  Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations.

Authors:  Thomas W Bastian; Joseph R Prohaska; Michael K Georgieff; Grant W Anderson
Journal:  Endocrinology       Date:  2010-06-23       Impact factor: 4.736

5.  The mechanism of vanadium-mediated developmental hypomyelination is related to destruction of oligodendrocyte progenitors through a relationship with ferritin and iron.

Authors:  Bozho Todorich; James O Olopade; Nodar Surguladze; Xuesheng Zhang; Elizabeth Neely; James R Connor
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

6.  Iron content of ferritin modulates its uptake by intestinal epithelium: implications for co-transport of prions.

Authors:  Solomon Raju Bhupanapadu Sunkesula; Xiu Luo; Dola Das; Ajay Singh; Neena Singh
Journal:  Mol Brain       Date:  2010-04-29       Impact factor: 4.041

Review 7.  Iron and intracerebral hemorrhage: from mechanism to translation.

Authors:  Xiao-Yi Xiong; Jian Wang; Zhong-Ming Qian; Qing-Wu Yang
Journal:  Transl Stroke Res       Date:  2013-12-21       Impact factor: 6.829

8.  Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: A novel neuro-immune axis.

Authors:  Brian Chiou; Elisabeth Lucassen; Michael Sather; Asha Kallianpur; James Connor
Journal:  Glia       Date:  2018-02-19       Impact factor: 7.452

9.  Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.

Authors:  D M Harrison; X Li; H Liu; C K Jones; B Caffo; P A Calabresi; P van Zijl
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-03       Impact factor: 3.825

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.